Yu Bingran,Chen Gong.Current status and recent advances of liver transplantation for pediatric hepatoblastoma[J].Journal of Clinical Pediatric Surgery,2025,(03):201-206.[doi:10.3760/cma.j.cn101785-202501039-001]
肝移植治疗儿童肝母细胞瘤的几个应用问题
- Title:
- Current status and recent advances of liver transplantation for pediatric hepatoblastoma
- Keywords:
- Hepatoblastoma; Liver Transplantation; Surgical Procedures; Operative; Prognosis; Child
- 摘要:
- 肝母细胞瘤是儿童最常见的肝脏原发性恶性肿瘤。尽管早期诊断、手术技术以及以铂类药物为基础的化疗方案均取得了较大进展,但仍有部分患儿的肿瘤在化疗后无法进行手术切除。对于这些晚期或不可切除的肝母细胞瘤,肝移植成为一种有效的治疗选择。近年来,肝移植在儿童肝母细胞瘤治疗中的应用取得了显著进展。本文旨在总结肝移植治疗儿童肝母细胞瘤的现状及进展,讨论肝移植的适应证及禁忌证、治疗策略及其效果,并分析其潜在的并发症。
- Abstract:
- Hepatoblastoma is the most common primary malignant liver tumor in children.Although significant advancements have been made in early diagnosis,surgical techniques,and platinum-based chemotherapy regimens,some tumors remain unresectable even after chemotherapy.For these advanced or unresectable cases,liver transplantation has emerged as an effective treatment option.In recent years,substantial progress has been achieved in applying liver transplantation for pediatric hepatoblastoma.This article aims to summarize the current status and developments in liver transplantation in treating children with hepatoblastoma,discuss indications and contraindications,strategies and outcomes,and analyze potential complications associated with the procedure.
参考文献/References:
[1] Czauderna P,Lopez-Terrada D,Hiyama E,et al.Hepatoblastoma state of the art:pathology,genetics,risk stratification,and chemotherapy[J].Curr Opin Pediatr,2014,26(1):19-28.DOI:10.1097/MOP.0000000000000046.
[2] Allan BJ,Parikh PP,Diaz S,et al.Predictors of survival and incidence of hepatoblastoma in the paediatric population[J].HPB (Oxford),2013,15(10):741-746.DOI:10.1111/hpb.12112.
[3] Huang HT,Wu L,Lu L,et al.Single-cell transcriptomics uncovers cellular architecture and developmental trajectories in hepatoblastoma[J].Hepatology,2023,77(6):1911-1928.DOI:10.1002/hep.32775.
[4] Trobaugh-Lotrario AD,Meyers RL,Tiao GM,et al.Pediatric liver transplantation for hepatoblastoma[J].Transl Gastroenterol Hepatol,2016,1:44.DOI:10.21037/tgh.2016.04.01.
[5] Cao YB,Wu SR,Tang HW.An update on diagnosis and treatment of hepatoblastoma[J].Biosci Trends,2024,17(6):445-457.DOI:10.5582/bst.2023.01311.
[6] Pham TH,Iqbal CW,Grams JM,et al.Outcomes of primary liver cancer in children:an appraisal of experience[J].J Pediatr Surg,2007,42(5):834-839.DOI:10.1016/j.jpedsurg.2006.12.065.
[7] Khaderi S,Guiteau J,Cotton RT,et al.Role of liver transplantation in the management of hepatoblastoma in the pediatric population[J].World J Transplant,2014,4(4):294-298.DOI:10.5500/wjt.v4.i4.294.
[8] Katzenstein HM,Malogolowkin MH,Krailo MD,et al.Doxorubicin in combination with cisplatin,5-flourouracil,and vincristine is feasible and effective in unresectable hepatoblastoma:a Children’s Oncology Group study[J].Cancer,2022,128(5):1057-1065.DOI:10.1002/cncr.34014.
[9] Cruz RJ Jr,Ranganathan S,Mazariegos G,et al.Analysis of national and single-center incidence and survival after liver transplantation for hepatoblastoma:new trends and future opportunities[J].Surgery,2013,153(2):150-159.DOI:10.1016/j.surg.2012.11.006.
[10] Otte JB,de Ville de Goyet J,Reding R.Liver transplantation for hepatoblastoma:indications and contraindications in the modern era[J].Pediatr Transplant,2005,9(5):557-565.DOI:10.1111/j.1399-3046.2005.00354.x.
[11] 儿童肝母细胞瘤诊疗规范(2019年版)编写审定专家组.儿童肝母细胞瘤诊疗规范(2019年版)[J].临床肝胆病杂志,2019,35(11):2431-2434.DOI:10.3969/j.issn.1001-5256.2019.11.008. Compilation and Examination Expert Group for Guidelines for the diagnosis and treatment of hepatoblastoma (2019).Guidelines for the diagnosis and treatment of hepatoblastoma (2019)[J].J Clin Hepatol,2019,35(11):2431-2434.DOI:10.3969/j.issn.1001-5256.2019.11.008.
[12] Meyers RL,Tiao GM,Dunn SP,et al.Liver transplantation in the management of unresectable hepatoblastoma in children[J].Front Biosci (Elite Ed),2012,4(4):1293-1302.DOI:10.2741/e460.
[13] Otte JB,Pritchard J,Aronson DC,et al.Liver transplantation for hepatoblastoma:results from the International Society of Pediatric Oncology (SIOP) study SIOPEL-1 and review of the world experience[J].Pediatr Blood Cancer,2004,42(1):74-83.DOI:10.1002/pbc.10376.
[14] Kappler R,von Schweinitz D.Molecular aspects of hepatoblastoma[M]//Zimmermann A,Perilongo G.Pediatric Liver Tumors.Berlin:Springer,2011:27-42.DOI:10.1007/978-3-642-14504-9_4.
[15] Lim IIP,Bondoc AJ,Geller JI,et al.Hepatoblastoma-the evolution of biology,surgery,and transplantation[J].Children (Basel),2018,6(1):1.DOI:10.3390/children6010001.
[16] Pondrom M,Pariente D,Mallon B,et al.Tumor rupture in hepatoblastoma:A high risk factor?[J].Pediatr Blood Cancer,2020,67(9):e28549.DOI:10.1002/pbc.28549.
[17] Uchida H,Sakamoto S,Sasaki K,et al.Surgical treatment strategy for advanced hepatoblastoma:resection versus transplantation[J].Pediatr Blood Cancer,2018,65(12):e27383.DOI:10.1002/pbc.27383.
[18] Fuchs J,Rabaux-Eygasier L,Ruping F,et al.Reappraisal of liver resection as an alternative to transplantation in locally advanced hepatoblastoma:a systematic review and analysis of pooled individual patient data[J].Pediatr Blood Cancer,2024,71(12):e31339.DOI:10.1002/pbc.31339.
[19] Pichlmayr R,Bretschneider HJ,Kirchner E,et al.Ex situ operation on the liver.A new possibility in liver surgery[J].Langenbecks Arch Chir,1988,373(2):122-126.DOI:10.1007/BF01262775.
[20] Hannoun L,Panis Y,Balladur P,et al.Ex-situ in-vivo liver surgery[J].Lancet,1991,337(8757):1616-1617.DOI:10.1016/0140-6736(91)93321-y.
[21] Honda M,Uchida K,Irie T,et al.Recent advances in surgical strategies and liver transplantation for hepatoblastoma[J].Cancer Med,2023,12(4):3909-3918.DOI:10.1002/cam4.5300.
[22] Shi SJ,Wang DL,Hu W,et al.Ex vivo liver resection and autotransplantation with cardiopulmonary bypass for hepatoblastoma in children:a case report[J].Pediatr Transplant,2018,22(7):e13268.DOI:10.1111/petr.13268.
[23] Warmann SW,Schenk A,Schaefer JF,et al.Computer-assisted surgery planning in children with complex liver tumors identifies variability of the classical couinaud classification[J].J Pediatr Surg,2016,51(11):1801-1806.DOI:10.1016/j.jpedsurg.2016.05.018.
[24] Souzaki R,Kinoshita Y,Ieiri S,et al.Three-dimensional liver model based on preoperative CT images as a tool to assist in surgical planning for hepatoblastoma in a child[J].Pediatr Surg Int,2015,31(6):593-596.DOI:10.1007/s00383-015-3709-9.
[25] de Freitas Paganoti G,Tannuri ACA,Dantas Marques AC,et al.Extensive hepatectomy as an alternative to liver transplant in advanced hepatoblastoma:a new protocol used in a pediatric liver transplantation center[J].Transplant Proc,2019,51(5):1605-1610.DOI:10.1016/j.transproceed.2019.03.004.
[26] Fonseca A,Gupta A,Shaikh F,et al.Extreme hepatic resections for the treatment of advanced hepatoblastoma:Are planned close margins an acceptable approach?[J].Pediatr Blood Cancer,2018,65(2):e26820.DOI:10.1002/pbc.26820.
[27] Fuchs J,Cavdar S,Blumenstock G,et al.POST-TEXT Ⅲ and Ⅳ hepatoblastoma:extended hepatic resection avoids liver transplantation in selected cases[J].Ann Surg,2017,266(2):318-323.DOI:10.1097/SLA.0000000000001936.
[28] Busweiler LAD,Wijnen MHWA,Wilde JCH,et al.Surgical treatment of childhood hepatoblastoma in the Netherlands (1990-2013)[J].Pediatr Surg Int,2017,33(1):23-31.DOI:10.1007/s00383-016-3989-8.
[29] Majno PE,Sarasin FP,Mentha G,et al.Primary liver resection and salvage transplantation or primary liver transplantation in patients with single,small hepatocellular carcinoma and preserved liver function:an outcome-oriented decision analysis[J].Hepatology,2000,31(4):899-906.DOI:10.1053/he.2000.5763.
[30] Umeda K,Okajima H,Kawaguchi K,et al.Prognostic and therapeutic factors influencing the clinical outcome of hepatoblastoma after liver transplantation:a single-institute experience[J].Pediatr Transplant,2018,22(2):e13113.DOI:10.1111/petr.13113.
[31] Boster JM,Superina R,Mazariegos GV,et al.Predictors of survival following liver transplantation for pediatric hepatoblastoma and hepatocellular carcinoma:experience from the Society of Pediatric Liver Transplantation (SPLIT)[J].Am J Transplant,2022,22(5):1396-1408.DOI:10.1111/ajt.16945.
[32] Meyers RL,Tiao G,de Ville de Goyet J,et al.Hepatoblastoma state of the art:pre-treatment extent of disease,surgical resection guidelines and the role of liver transplantation[J].Curr Opin Pediatr,2014,26(1):29-36.DOI:10.1097/MOP.0000000000000042.
[33] Aguado A,Ristagno R,Towbin AJ,et al.Transarterial radioembolization with yttrium-90 of unresectable primary hepatic malignancy in children[J].Pediatr Blood Cancer,2019,66(7):e27510.DOI:10.1002/pbc.27510.
[34] Otte JB,Meyers R.Pluto first report[J].Pediatr Transplant,2010,14(7):830-835.DOI:10.1111/j.1399-3046.2010.01395.x.
[35] Sakamoto S,Kasahara M,Mizuta K,et al.Nationwide survey of the outcomes of living donor liver transplantation for hepatoblastoma in Japan[J].Liver Transpl,2014,20(3):333-346.DOI:10.1002/lt.23803.
[36] Marsh AM,Lo L,Cohen RA,et al.Sorafenib and bevacizumab for recurrent metastatic hepatoblastoma:stable radiographic disease with decreased AFP[J].Pediatr Blood Cancer,2012,59(5):939-940.DOI:10.1002/pbc.24171.
[37] Wagner F,Henningsen B,Lederer C,et al.Rapamycin blocks hepatoblastoma growth in vitro and in vivo implicating new treatment options in high-risk patients[J].Eur J Cancer,2012,48(15):2442-2450.DOI:10.1016/j.ejca.2011.12.032.
[38] Sindhi R.Sirolimus in pediatric transplant recipients[J].Transplant Proc,2003,35(3 Suppl):113S-114S.DOI:10.1016/s0041-1345(03)00223-9.
[39] Hendrickson RJ,Sujka J,Fischer R,et al.Indications and efficacy of conversion from tacrolimus-to sirolimus-based immunosuppression in pediatric patients who underwent liver transplantation for unresectable hepatoblastoma[J].Pediatr Transplant,2019,23(3):e13369.DOI:10.1111/petr.13369.
[40] Ramos-Gonzalez G,LaQuaglia M,O’Neill AF,et al.Long-term outcomes of liver transplantation for hepatoblastoma:a single-center 14-year experience[J].Pediatr Transplant,2018,22(6):e13250.DOI:10.1111/petr.13250.
[41] Horvat N,Marcelino ASZ,Horvat JV,et al.Pediatric liver transplant:techniques and complications[J].Radiographics,2017,37(6):1612-1631.DOI:10.1148/rg.2017170022.
[42] Yeh YT,Chen CY,Tseng HS,et al.Enlarging vascular stents after pediatric liver transplantation[J].J Pediatr Surg,2017,52(12):1934-1939.DOI:10.1016/j.jpedsurg.2017.08.060.
[43] Jafri M,Protheroe A.Cisplatin-associated thrombosis[J].Anticancer Drugs,2008,19(9):927-929.DOI:10.1097/CAD.0b013e3283100e9c.
[44] Moosburner S,Schmelzle M,Sch?ning W,et al.Liver transplantation is highly effective in children with irresectable hepatoblastoma[J].Medicina (Kaunas),2021,57(8):819.DOI:10.3390/medicina57080819.
[45] Kochhar G,Parungao JM,Hanouneh IA,et al.Biliary complications following liver transplantation[J].World J Gastroenterol,2013,19(19):2841-2846.DOI:10.3748/wjg.v19.i19.2841.
[46] Laurence JM,Sapisochin G,DeAngelis M,et al.Biliary complications in pediatric liver transplantation:Incidence and management over a decade[J].Liver Transpl,2015,21(8):1082-1090.DOI:10.1002/lt.24180.
[47] Boeva I,Karagyozov PI,Tishkov I.Post-liver transplant biliary complications:current knowledge and therapeutic advances[J].World J Hepatol,2021,13(1):66-79.DOI:10.4254/wjh.v13.i1.66.
[48] Monroe EJ,Shin DS,Young VA,et al.Evaluation and management of biliary complications after pediatric liver transplantation:pearls and pitfalls for percutaneous techniques[J].Pediatr Radiol,2022,52(3):570-586.DOI:10.1007/s00247-021-05212-7.
[49] Héry G,Franchi-Abella S,Habes D,et al.Initial liver transplantation for unresectable hepatoblastoma after chemotherapy[J].Pediatr Blood Cancer,2011,57(7):1270-1275.DOI:10.1002/pbc.23301.
[50] Pu J R,Li H,Li S,et al.Current trends and prospects of surgical techniques for hepatoblastoma[J].Cancer Med,2024,13(1):e6795.DOI:10.1002/cam4.6795.
相似文献/References:
[1]杨振宇,陈福真,李滨,等.小儿亲体部分肝移植治疗肝母细胞瘤(附1例报告)[J].临床小儿外科杂志,2007,6(02):12.
[2]唐艳,刘洋,王紫娟,等. 个体化干预模式在儿童肝移植受者术后随访中的应用[J].临床小儿外科杂志,2016,15(01):41.
[3]余晨,詹江华,高伟,等.胆道闭锁Ｋａｓａｉ术后肝移植患儿不同自体肝生存的临床与病理分析[J].临床小儿外科杂志,2017,16(06):552.
[4]陈立才,李朋飞,黄一敏,等. 抗EpCAM单克隆抗体治疗肝母细胞瘤的动物实验研究[J].临床小儿外科杂志,2019,18(01):63.
Chen Licai,Li Pengfei,Huang Yimin,et al. Targeting therapy of antiEpCAM monoclonal antibody in hepatoblastoma animal model.[J].Journal of Clinical Pediatric Surgery,2019,18(03):63.
[5]成英杰,单慈,石寒菡,等.MicroRNAs在肝母细胞瘤诊断、鉴别诊断及预后评估中的研究进展[J].临床小儿外科杂志,2019,18(08):660.[doi:10.3969/j.issn.1671-6353.2019.08.009]
Cheng Yingjie,Shan Ci,Shi Hanhan,et al.Research advances of MicroRNAs in the diagnosis,differential diagnosis and prognostic evaluation of hepatoblastoma[J].Journal of Clinical Pediatric Surgery,2019,18(03):660.[doi:10.3969/j.issn.1671-6353.2019.08.009]
[6]彭宇明,司中州,袁妙贤,等.儿童肝移植20例诊治分析[J].临床小儿外科杂志,2019,18(08):681.[doi:10.3969/j.issn.1671-6353.2019.08.013]
Peng Yuming,Si Zhongzhou,Yuan Miaoxian,et al.Diagnoses and treatments of hepatic transplantation in 20 children[J].Journal of Clinical Pediatric Surgery,2019,18(03):681.[doi:10.3969/j.issn.1671-6353.2019.08.013]
[7]王焕民.开展新技术 提高儿童肝胆肿瘤手术治疗水平[J].临床小儿外科杂志,2020,19(05):377.[doi:10.3969/j.issn.1671-6353.2020.05.001]
Wang Huanmin.Adopting new technology to optimize the surgical treatment of hepatobiliary cancer in children[J].Journal of Clinical Pediatric Surgery,2020,19(03):377.[doi:10.3969/j.issn.1671-6353.2020.05.001]
[8]董岿然.联合肝脏离断和门静脉结扎二步肝切除术在儿童肝肿瘤治疗中的应用[J].临床小儿外科杂志,2020,19(05):382.[doi:10.3969/j.issn.1671-6353.2020.05.002]
Dong Kuiran.Application of associated liver partition and portal vein ligation for staged hepatectomy in the treatment of liver tumors in children[J].Journal of Clinical Pediatric Surgery,2020,19(03):382.[doi:10.3969/j.issn.1671-6353.2020.05.002]
[9]沈秋龙,陈亚军,彭春辉,等.肝脏硬度测量值预测胆道闭锁术后五年自体肝生存的价值研究[J].临床小儿外科杂志,2020,19(06):486.[doi:10.3969/j.issn.1671-6353.2020.06.005]
Shen Qiulong,Chen Yajun,Peng Chunhui,et al.Predicting five-year native liver survival after Kasai procedure of biliary atresia by liver stiffness measurement[J].Journal of Clinical Pediatric Surgery,2020,19(03):486.[doi:10.3969/j.issn.1671-6353.2020.06.005]
[10]隆琦,钭金法,陈菲,等.胆道闭锁Kasai术后自体肝生存良好患儿的营养状况调查[J].临床小儿外科杂志,2020,19(06):491.[doi:10.3969/j.issn.1671-6353.2020.06.006]
Long Qi,Tou Jinfa,Chen Fei,et al.Nutritional status of children with biliary atresia surviving well after Kasai surgery[J].Journal of Clinical Pediatric Surgery,2020,19(03):491.[doi:10.3969/j.issn.1671-6353.2020.06.006]
备注/Memo
收稿日期:2025-1-13。
基金项目:国家儿童医学中心临床-基础双结对重点项目(EKSJD202409);上海市临床重点专科(shslczdzk05703);2024年医疗服务与保障能力提升(国家临床重点专科建设)项目(10000015Z155080000004)
通讯作者:陈功,Email:chengongzlp@hotmail.com